Connect with us

Health

Read the MAHA strategy report

Published

on

Read the MAHA strategy report

ADVANCE RESEARCH

Vaccine Injury

HHS, in collaboration with NIH, will investigate vaccine injuries with improved data collection and analysis, including through a new vaccine injury research program at the NIH Clinical Center that may expand to centers around the country.

Water Quality

The EPA and USDA, along with other relevant Federal partners and in collaboration with NIH, will assess ongoing evaluations of water contaminants and update guidance and prioritizations of certain contaminants appropriately. For example, EPA will review new scientific information on the potential health risks of fluoride in drinking water to inform Centers for Disease Control and Prevention (CDC) recommendations. Additionally, USDA, through its Research, Education, and Economics mission area, in consultation with the Farm Production and Conservation mission area, will continue research on ways to improve water quality and adoption of applicable conservation practices. Agency research could also include research to inform the understanding of levels of pharmaceuticals in our water supply that could be adversely affecting animal and human health.

Air Quality

The EPA and NIH will study air quality impacts on children’s health and utilize existing research programs to improve data collection and analysis.

Microplastics and Synthetics

HHS, in collaboration with NIH and EPA, will complete an evaluation of the risks and exposures of microplastics and synthetics, including in common products such as textiles.

Prescribing Patterns and Impact on Mental Health

HHS (inclusive of the Administration for Children and Families (ACF), Substance Abuse and Mental Health Services Administration, FDA, NIH, and CMS) will form a mental health diagnosis and prescription working group to evaluate prescription patterns for selective serotonin reuptake inhibitors, antipsychotics, mood stabilizers, stimulants, and other relevant drugs for children. HHS will also evaluate the therapeutic harms and benefits of current diagnostic thresholds, overprescription trends, and evidence-based solutions that can be scaled-up to improve mental health, including through school-based interventions, diet, and foster care services. NIH will conduct research as appropriate. FDA will update labels for older, generic drugs to better reflect the latest science.

Food for Health

HHS, the Department of Veterans Affairs (VA), and USDA will study the impact of programs that implement food and lifestyle interventions to improve health outcomes and decrease costs. The NIH Office of Nutrition will coordinate research initiatives to improve rigorous studies and maximize impact, including through large- scale randomized control trials.

Nutrition

NIH will partner with FDA, USDA, and the Administration for a Healthy America (AHA) to conduct high- quality nutrition research and ingredient assessments. As part of this effort, NIH will expand research on dietary patterns that support metabolic health. NIH and HHS will take steps to fully utilize the newly created FDA and NIH Joint Nutrition Regulatory Science Program. USDA will prioritize precision nutrition research,

MAKE AMERICA HEALTHY AGAIN

MAHA

PRESIDENT DONALD J. TRUMP

5

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Health

Why microdosing Ozempic could become as common as taking a multivitamin

Published

on

Why microdosing Ozempic could become as common as taking a multivitamin

NEWYou can now listen to Fox News articles!

They may have gained popularity for diabetes and weight loss, but GLP-1 medications like Ozempic and Wegovy have been linked to ever-expanding health benefits.

In fact, some doctors — including Dr. Terry Dubrow, a plastic surgeon and TV personality based in Newport Beach, California — recommend that everyone takes a low daily dose, even if they don’t need to lose weight.

Dubrow spoke on camera with Fox News Digital about the benefits of “microdosing” these medications. (See the video at the top of this article.)

How GLP-1s work

GLP-1 receptor agonists work by mimicking a hormone called glucagon-like peptide-1, which is released from the gut after eating.

Advertisement

The drugs help to regulate blood sugar, slow down emptying of the stomach and diminish appetite, and have also been shown to reduce the risk of heart disease.

Dr. Terry Dubrow, a plastic surgeon and TV personality based in Newport Beach, California, recommends that everyone takes a low daily dose of a GLP-1, even if they don’t need to lose weight. (Terry Dubrow)

“Sugar’s the enemy, and these drugs affect sugar in your blood,” Dubrow told Fox News Digital. “They affect the way insulin reacts.”

GLP-1s help insulin move the glucose (sugar) out of the bloodstream and into the body’s cells, where it can be used for energy or stored, the doctor said. The drugs also help to prevent the inflammation and damage sugar can cause in the blood vessels, nerves and organs.

‘NEXT OZEMPIC’ AIMS TO DELIVER 30% WEIGHT LOSS WITH FEWER SIDE EFFECTS

Advertisement

“I don’t think anyone would argue that if there was a way to manipulate the amount of sugar and inflammation your body’s exposed to, that is something we want to lean into. And that’s exactly what these drugs do,” Dubrow added.

In addition to regulating blood sugar and triggering weight loss, GLP-1s have also been approved to reduce the risk of cardiovascular events and kidney disease in certain patients.

“I have never seen a drug in the history of medicine be on such a rapid path to approval.”

“Even if you’re not overweight, being on these GLP-1 drugs … helps to minimize and prevent a repeat recurrent heart attack,” Dubrow said.

Semaglutide was also recently approved for MASH (metabolic dysfunction-associated steatohepatitis), an inflammatory form of fatty liver disease.

Advertisement
Dr. Terry Dubrow speaking to Fox News Digital

Dubrow spoke on camera with Fox News Digital about the benefits of GLP-1 medications. (Fox News Digital)

GLP-1s are also being studied for potential cognitive benefits in Parkinson’s patients.

“I have never seen a drug in the history of medicine be on such a rapid path to approval,” Dubrow said.

The case for microdosing

Along with other experts, Dubrow is an advocate for microdosing, which is where people take low, steady doses of GLP-1s every day, even if they don’t need them for diabetes or obesity.

While patients with diabetes take doses that increase every four weeks, microdosing entails using a low-level dose that doesn’t go up.

WEIGHT LOSS TOUGHER WITH ULTRA-PROCESSED FOODS LURKING IN NEARLY EVERY MEAL, SAY EXPERTS

Advertisement

A younger population on TikTok has zeroed in on microdosing, Dubrow pointed out — and he thinks everyone should be doing it.

“I am obsessed with the concept of microdosing,” he said. “I think maybe half the starting dose for diabetes is the way to go — and you probably don’t need it every seven days, it’s probably every 10 days, just to sort of modulate the amount of sugar in the blood.”

Woman holding GLP-1 medication

“Even if you’re not overweight, being on these GLP-1 drugs … helps to minimize and prevent a repeat recurrent heart attack,” Dubrow said. (iStock)

The doctor noted that there are still a lot of unknowns with GLP-1 medications.

“We are just figuring out now how to use these drugs for different indications, for different reasons,” he said. “We’re learning as we’re using it.”

“I am obsessed with the concept of microdosing.”

Advertisement

As with other drugs, like Botox, Dubrow said there is a bit of “human experimentation” at play.

“We’re figuring it out, and we’re teaching the medical profession how to do it. The patients are telling us how to use these drugs.”

Potential risks

GLP-1 medications have been linked to several potential risks. The most prevalent is gastrointestinal issues, such as nausea and vomiting.

Others have reported an increased risk of pancreatitis, muscle loss and thyroid tumors.

“I read every study that comes out on these drugs, and I can tell you, it’s very clear they don’t cause pancreatitas,” Dubrow said. 

Advertisement

OZEMPIC PUSH FOR SENIORS? SOME DOCTORS SAY MORE PEOPLE AGE 65 AND OVER SHOULD BE ON IT

“In fact, if you really look at the populations who have been using it, pancreatitis is less in those populations.”

Dubrow confirmed, however, that the drug has been linked to an increased risk of the very rare medullary cancer of the thyroid. 

patient at doctor

Those who experience severe side effects from GLP-1s should talk to a doctor, Dubrow advised.  (iStock)

“If you have a family history of that, that’s a contraindication to you using these drugs,” he said. 

Regarding the digestive side effects, the doctor said the medications do slow down the GI tract, but it’s been shown that the body adjusts to that over time. 

Advertisement

“These particular drugs are natural hormones that occur in our small intestine, and you get used to the side effects. They go away.”

The severity of side effects is linked to the dose amount, Dubrow noted.

“The low dose, particularly the microdose, really has a low propensity toward the constipation, the nausea, the potential diarrhea, the GERD (reflux),” he said. “I think those side effects are less significant for people who microdose.”

To counteract the risk of muscle loss, Dubrow recommends increasing protein intake and incorporating resistance training as a core component of an exercise routine. 

Advertisement

Those who do experience severe side effects should talk to a doctor, he advised. 

Close-up of Ozempic pens and person injecting needle in background

Off-label use of GLP-1s, such as for microdosing, is common, Dubrow said — “but finding a doctor willing to prescribe can be difficult.” (iStock)

Drugmakers weigh in

When contacted by Fox News Digital, manufacturers of GLP-1 medications warned against microdosing the products.

“Lilly does not have any data on the benefits or risks of microdosing of Zepbound and Mounjaro,” said a spokesperson for Eli Lilly, maker of the GLP-1 drugs Mounjaro and Zepbounda. “Both autoinjectors and Zepbound vials are approved for single-use only — dose-splitting or ‘microdosing’ is not contemplated by the FDA label. As such, off-label use of Zepbound and Mounjaro may pose patient safety risks.”

“Off-label use of Zepbound and Mounjaro may pose patient safety risks.”

Novo Nordisk, maker of Ozempic and Wegovy, said it does not condone “misuse” of its products. 

Advertisement

“It’s important to understand that for Wegovy, only the marked doses on the single-use, fixed-dose pens (0.25, 0.5, 1.0, 1.7 and 2.4 mg) are approved for use and represent an authentic FDA-approved medicine,” a spokesperson told Fox News Digital. “The starting dose of Wegovy® is 0.25 mg once a week, and the dose will gradually increase every four weeks. Patients should work with their healthcare professional to select either 1.7 mg or 2.4 mg for the maintenance dose.” 

CHEAP OZEMPIC KNOCK-OFFS HAVE RISEN IN POPULARITY

“It is also important to note that the authentic Wegovy injectable pen is designed as a single-use pen, the dose is already set, and should not be altered or tampered with, and the pen must be disposed after one use.” 

“Ozempic is a multi-use pen with one pen and multiple needles,” the spokesperson added.

Accessing GLP-1s

Dubrow said he’s not concerned about supply issues amid the growing popularity of GLP-1s, as major drug companies have the resources to “scale up” to meet the demand.

Advertisement

Off-label use of GLP-1s, such as for microdosing, is common, Dubrow said — “but finding a doctor willing to prescribe can be difficult.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The doctor cautioned against buying these drugs from online marketplaces, which he referred to as the “wild wild west.”

“It’s hard to find these drugs online from compounding pharmacies, because essentially they’re going rogue — it’s illegal. They’re not allow to do it,” he warned. 

“These drugs are natural hormones that occur in our small intestine, and you get used to the side effects.”

Advertisement

“So if you’re getting it from rogue pharmacies that aren’t allowed to do it or are willing to bend the rules, what is it? You don’t know what you’re getting.”

“It may be an adulterated, weird version that has side effects or that’s not effective.”

Looking ahead

There are several next-generation drugs in development that combine multiple hormone pathways, Dubrow said.

“I predict within five years, we’ll have a pill … designed to manipulate hunger and insulin resistance,” he predicted.

For more Health articles, visit www.foxnews.com/health

Advertisement

Overall, Dubrow said, GLP-1s are “here to stay.”

“They’re just going to get better, and we’re going to learn how to use them in a more appropriate and clinically effective way,” he said. “So fasten your seatbelt. If you’re not on them now, you will be later.”

Advertisement
Continue Reading

Health

How Brazilian ‘Mounjaro’ Drink Helped One Woman Lose 103 Lbs

Published

on

How Brazilian ‘Mounjaro’ Drink Helped One Woman Lose 103 Lbs


Advertisement


Brazilian ‘Mounjaro’ Drink Helped One Woman Lose 103 Lbs—Here’s How | Woman’s World




























Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Heart surgeon reveals what to eat (and not eat) for optimal cardiac health

Published

on

Heart surgeon reveals what to eat (and not eat) for optimal cardiac health

NEWYou can now listen to Fox News articles!

Heart disease is the No. 1 killer in America, accounting for one in five deaths, according to the U.S. Centers for Disease Control and Prevention (CDC).

While multiple lifestyle factors can cause heart health to decline, nutrition is a large component, experts confirm.

In an on-camera interview with Fox News Digital, cardiothoracic surgeon Dr. Jeremy London shared how nutrition can sometimes be a sensitive topic, as diets can work differently for every individual.

TWO KEY HEART HEALTH METRICS COULD DETERMINE HOW LONG YOU’LL LIVE

Advertisement

A focus on general dietary guidelines, including eating whole foods and avoiding processed foods, is a great place to start, according to the Savannah, Georgia-based expert.

Reaping the benefits of nutrition for heart health is about balance, he said.

A cardiothoracic surgeon emphasizes being “mindful of what you’re putting in your mouth.” (iStock)

“If I can eat whole foods 80% of the time, that’s a win for me,” he said. “And I think that’s reasonable.”

Hydration is also an important component of heart health, London said. He recommends reaching for more water and limiting alcohol consumption.

Advertisement

THE GREAT EGG DEBATE IS OVER AS SCIENCE WEIGHS IN ABOUT THE FOOD’S CHOLESTEROL IMPACT

“That being said, your body, your rules, as long as you know the facts,” he commented. “Alcohol is a personal choice, but it’s really toxic to every cell in the body.”

“From a nutritional standpoint, be mindful of what you’re putting in your mouth — try and focus on whole foods and limit alcohol or remove it altogether.”

Serving salad for lunch onto a plate with protein

The U.S. Department of Agriculture recommends filling half of your plate with fruits and vegetables. (iStock)

Diet is especially important for those with heart health-related conditions such as high cholesterol, London said, as they should limit foods high in saturated fat.

Some foods, such as eggs, have been linked to high cholesterol in the past, but recent research has revealed that eggs can be a heart-healthy food.

Advertisement

London commented that eggs are a “wonderful nutritional source,” but added that the nutritional “pendulum” should always stay at the center.

“If I can eat whole foods 80% of the time, that’s a win for me.”

“The dietary portion of the endogenous cholesterol (produced naturally inside the body) is maybe not as important as we had thought previously,” he said.

“There are people who are ‘hyper responders’ and should avoid those situations, but [otherwise], eggs in moderation are a great source of protein and certain vitamins and minerals that you can’t get elsewhere.”

Advertisement
hand holding a piece of toasted bread with scrambled eggs on top

London called eggs a “wonderful nutritional source,” but some people with certain conditions should eat them in moderation. (iStock)

Individuals with high cholesterol and other heart conditions should limit refined flours and sugars, London suggested, as there’s a “direct correlation between blood glucose and triglyceride levels.”

Exercise is also an important component for better balance and results, experts agree.

What’s the 80/20 rule?

The 80/20 approach has been endorsed by experts as a proven concept for healthy eating.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

A recent medically reviewed article by WebMD detailed how eating healthy meals 80% of the time allows for “more freedom” with the other 20%. The approach can affect weight differently depending on how it’s done.

Advertisement

“Because the 80/20 diet features a healthy, balanced diet with a few splurges, it may help you shed a few pounds if you use it to cut down on fattening foods and watch your calories,” the article states. “Anytime you burn more calories than you take in, you’re likely to lose weight.”

heart healthy foods

An 80/20 approach to nutrition can be enough to support a healthy heart, according to experts. (iStock)

The U.S. Department of Agriculture’s federal diet guidelines recommend filling half of your plate with fruits and vegetables, making half of your grains whole grain, varying lean protein, and including a serving of low-fat or fat-free dairy.

Sugars, sodium and saturated fats should all be limited, the guidelines state.

For more Health articles, visit www.foxnews.com/health

Individuals with specific conditions, such as diabetes, should consult their doctor before starting the 80/20 eating plan.

Advertisement

Continue Reading

Trending